Phibro Animal Health (PAHC) Debt/Equity Ratio: History & Chart

Phibro Animal Health Corporation(PAHC)

Drug Manufacturers - Specialty & Generic · Teaneck, NJ

$37.17-0.02 (-0.07%)

Delayed quote: Oct 6, 2026, 12:04 PM EDT

About Phibro Animal Health Corporation

Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.

Teaneck, NJ

2,605 employees

www.pahc.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Daniel Bendheim

View full financials

PAHC Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

2.05

DEBT TO EQUITY RATIO AVG TTM

2.35

DEBT TO EQUITY RATIO AVG 3Y

2.26

DEBT TO EQUITY RATIO AVG 5Y

1.96

DEBT TO EQUITY RATIO AVG 10Y

1.94

DEBT TO EQUITY RATIO AVG 15Y

2.06

DEBT TO EQUITY RATIO AVG 20Y

1.51

CURRENT VS TTM AVG

-12.80%

CURRENT VS 3Y AVG

-9.49%

CURRENT VS 5Y AVG

+4.23%

CURRENT VS 10Y AVG

+5.44%

CURRENT VS 15Y AVG

-0.46%

CURRENT VS 20Y AVG

+35.16%

SECTOR MEDIAN · HEALTHCARE

0.12

median of 648 covered companies

CURRENT VS SECTOR MEDIAN

+1605.18%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Phibro Animal Health Corporation (PAHC)	$1.51B	2.05	2.35	2.26	1.96
Eton Pharmaceuticals, Inc. (ETON)vs ›	$1.51B	0.62	1.21	0.82	0.68
GH Research PLC (GHRS)vs ›	$1.49B	0.00	0.00	0.00	0.00
Rapport Therapeutics, Inc. Common Stock (RAPP)vs ›	$1.49B	0.02	0.01	0.18	0.18
Nutex Health, Inc. (NUTX)vs ›	$1.53B	0.88	1.70	2.67	2.33
Innoviva, Inc. (INVA)vs ›	$1.54B	0.22	0.44	0.63	0.69
uniQure N.V. (QURE)vs ›	$1.54B	0.19	2.70	1.22	0.84
Certara, Inc. (CERT)vs ›	$1.47B	0.30	0.15	0.22	0.26
Healthcare Services Group, Inc. (HCSG)vs ›	$1.46B	0.03	0.04	0.07	0.06
Braveheart Bio, Inc. (BRVE)vs ›	$1.46B	N/A	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Phibro Animal Health Corporation (PAHC)

$1.51B

2.05

2.35

2.26

1.96

Eton Pharmaceuticals, Inc. (ETON)vs ›

$1.51B

0.62

1.21

0.82

0.68

GH Research PLC (GHRS)vs ›

$1.49B

0.00

Rapport Therapeutics, Inc. Common Stock (RAPP)vs ›

$1.49B

0.02

0.01

0.18

Nutex Health, Inc. (NUTX)vs ›

$1.53B

0.88

1.70

2.67

2.33

Innoviva, Inc. (INVA)vs ›

$1.54B

0.22

0.44

0.63

0.69

uniQure N.V. (QURE)vs ›

$1.54B

0.19

2.70

1.22

0.84

Certara, Inc. (CERT)vs ›

$1.47B

0.30

0.15

0.22

0.26

Healthcare Services Group, Inc. (HCSG)vs ›

$1.46B

0.03

0.04

0.07

0.06

Braveheart Bio, Inc. (BRVE)vs ›

$1.46B

N/A

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Phibro Animal Health Corporation (PAHC)?

The debt to equity ratio for PAHC stock is 2.05.

Is Phibro Animal Health Corporation's debt to equity ratio high or low?

The debt to equity ratio of 2.05 is in line with its 5-year average of 1.96, near the low end of its 5-year range (1.71–3.20).

What is the TTM average debt to equity ratio for Phibro Animal Health Corporation (PAHC)?

The TTM average debt to equity ratio for PAHC stock is 2.35.

What is the 3Y average debt to equity ratio for Phibro Animal Health Corporation (PAHC)?

The 3Y average debt to equity ratio for PAHC stock is 2.26.

What is the 5Y average debt to equity ratio for Phibro Animal Health Corporation (PAHC)?

The 5Y average debt to equity ratio for PAHC stock is 1.96.

What is the 10Y average debt to equity ratio for Phibro Animal Health Corporation (PAHC)?

The 10Y average debt to equity ratio for PAHC stock is 1.94.

What is the 15Y average debt to equity ratio for Phibro Animal Health Corporation (PAHC)?

The 15Y average debt to equity ratio for PAHC stock is 2.06.

What is the 20Y average debt to equity ratio for Phibro Animal Health Corporation (PAHC)?

The 20Y average debt to equity ratio for PAHC stock is 1.51.

DATE	DEBT TO EQUITY RATIO
2026-06-30	2.05
2026-03-31	2.18
2025-12-31	2.33
2025-09-30	2.52
2025-06-30	2.67
2025-03-31	2.89
2024-12-31	3.20
2024-09-30	1.98
2024-06-30	2.05
2024-03-31	1.94
2023-12-31	1.89
2023-09-30	1.90
2023-06-30	1.81
2023-03-31	1.90
2022-12-31	1.91
2022-09-30	1.91
2022-06-30	1.79
2022-03-31	1.71
2021-12-31	1.82
2021-09-30	1.88
2021-06-30	1.79
2021-03-31	1.92
2020-12-31	1.93
2020-09-30	2.19
2020-06-30	2.18
2020-03-31	2.00
2019-12-31	1.83
2019-09-30	2.02
2019-06-30	1.51
2019-03-31	1.54
2018-12-31	1.58
2018-09-30	1.69
2018-06-30	1.69
2018-03-31	1.67
2017-12-31	1.88
2017-09-30	1.96
2017-06-30	2.07
2017-03-31	2.22
2016-12-31	2.92
2016-09-30	3.35
2016-06-30	3.90
2016-03-31	4.72
2015-12-31	5.72
2015-09-30	13.55
2015-06-30	9.77
2015-03-31	12.45
2014-12-31	11.06
2014-09-30	13.36
2014-06-30	19.10
2014-03-31	-4.76
2013-12-31	-5.73
2013-09-30	-5.51
2013-06-30	-5.30
2013-03-31	0.00
2012-12-31	0.00
2012-09-30	0.00
2009-12-31	0.00
2009-09-30	0.00
2009-06-30	0.00
2009-03-31	0.00
2008-12-31	0.00
2008-09-30	0.00
2008-06-30	0.00
2008-03-31	0.00
2007-12-31	0.00
2007-09-30	0.00
2007-06-30	0.00
2007-03-31	0.00
2006-12-31	0.00
2006-09-30	0.00
2006-06-30	0.00
2006-03-31	-3.61
2005-12-31	-3.60
2005-09-30	-3.97
2005-06-30	-4.11
2005-03-31	-4.57
2004-12-31	-3.01
2004-09-30	-2.76
2004-06-30	-2.66
2004-03-31	-3.58
2003-12-31	-3.93
2003-09-30	-1.70
2003-06-30	-1.68
2003-03-31	-1.91
2002-12-31	-2.16
2002-09-30	-2.48

DATE

DEBT TO EQUITY RATIO

2026-06-30

2.05

2026-03-31

2.18

2025-12-31

2.33

2025-09-30

2.52

2025-06-30

2.67

2025-03-31

2.89

2024-12-31

3.20

2024-09-30

1.98

2024-06-30

2.05

2024-03-31

1.94

2023-12-31

1.89

2023-09-30

1.90

2023-06-30

1.81

2023-03-31

1.90

2022-12-31

1.91

2022-09-30

1.91

2022-06-30

1.79

2022-03-31

1.71

2021-12-31

1.82

2021-09-30

1.88

2021-06-30

1.79

2021-03-31

1.92

2020-12-31

1.93

2020-09-30

2.19

2020-06-30

2.18

2020-03-31

2.00

2019-12-31

1.83

2019-09-30

2.02

2019-06-30

1.51

2019-03-31

1.54

2018-12-31

1.58

2018-09-30

1.69

2018-06-30

1.69

2018-03-31

1.67

2017-12-31

1.88

2017-09-30

1.96

2017-06-30

2.07

2017-03-31

2.22

2016-12-31

2.92

2016-09-30

3.35

2016-06-30

3.90

2016-03-31

4.72

2015-12-31

5.72

2015-09-30

13.55

2015-06-30

9.77

2015-03-31

12.45

2014-12-31

11.06

2014-09-30

13.36

2014-06-30

19.10

2014-03-31

-4.76

2013-12-31

-5.73

2013-09-30

-5.51

2013-06-30

-5.30

2013-03-31

0.00

2012-12-31

0.00

2012-09-30

0.00

2009-12-31

0.00

2009-09-30

0.00

2009-06-30

0.00

2009-03-31

0.00

2008-12-31

0.00

2008-09-30

0.00

2008-06-30

0.00

2008-03-31

0.00

2007-12-31

0.00

2007-09-30

0.00

2007-06-30

0.00

2007-03-31

0.00

2006-12-31

0.00

2006-09-30

0.00

2006-06-30

0.00

2006-03-31

-3.61

2005-12-31

-3.60

2005-09-30

-3.97

2005-06-30

-4.11

2005-03-31

-4.57

2004-12-31

-3.01

2004-09-30

-2.76

2004-06-30

-2.66

2004-03-31

-3.58

2003-12-31

-3.93

2003-09-30

-1.70

2003-06-30

-1.68

2003-03-31

-1.91

2002-12-31

-2.16

2002-09-30

-2.48

Debt to Equity Ratio: 2.05

PAHC Debt to Equity Ratio

PAHC Average Debt to Equity Ratio Chart

PAHC Current vs Average Debt to Equity Ratio Chart

PAHC Debt to Equity Ratio Metrics

PAHC Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

PAHC Debt to Equity Ratio History

Related Metrics